Mission Health issued the following announcement on Oct. 16.
A booster dose of the Pfizer-BioNTech COVID-19 vaccine was approved for specific populations last month by the U.S. Food and Drug Administration (FDA). This week, the FDA approved booster doses for other COVID-19 vaccines (Moderna and Johnson & Johnson).
-The eligibility criteria for the Moderna booster is identical to that which was approved for the Pfizer-BioNTech booster, focused on patients age 65 and older and others in specific higher risk categories.
-The eligibility criteria for the Johnson & Johnson booster is broader, including adults aged 18 and older at least two months following initial vaccination with the single-shot vaccine.
The FDA is also authorizing the use of heterologous (or “mix and match”) booster dose. This means that a single booster dose of any of the available COVID-19 vaccines may be administered as a booster following completion of primary vaccination with a different available COVID-19 vaccine.
Please consult with a physician if you have specific questions about COVID-19 vaccine booster shots. Refer to the FDA website for the specifics on these developments. The CDC website is also a good source to stay informed of any new recommendations regarding the vaccine booster strategy.
https://www.fda.gov/.../coronavirus-covid-19-update-fda...
https://www.cdc.gov/coronavirus/2019-ncov/whats-new-all.html
Original source can be found here.
Source: Mission Health
Alerts Sign-up